Scarring May Raise Death Risk from Fatty Liver Disease
Study looked at liver condition not tied to alcoholism Source: HealthDay Related MedlinePlus Pages: Cirrhosis, Liver Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 16, 2013 Category: Consumer Health News Source Type: news

Liver transplantation for patients with genetic liver conditions has high survival rate
This study is a first-of-its-kind, single-institution comparison of outcomes for both pediatric and adult patients undergoing liver transplantation for lethal genetic syndromes. Researchers found that children with genetic disorders that cause fibrosis, cirrhosis, and other liver conditions, which can affect other organs, have a good chance of still being alive five -- and even 20 years after a liver transplant operation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2013 Category: Global & Universal Source Type: news

Calling On The UK To Implement Minimum Pricing For Alcohol
According to WHO, liver cirrhosis accounts for 1.8% (i.e. 170,000) of all deaths in Europe. In recent years liver cirrhosis has become a serious health threat in some Western European countries such as Ireland and the United Kingdom, where over the last 10 years the associated mortality has increased . The European Association for the Study of the Liver (EASL) urges the UK government to press ahead with its proposed implementation of the minimum unit pricing of alcohol... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 17, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news

Do Nutritional Supplements Improve Cirrhosis Outcomes?Do Nutritional Supplements Improve Cirrhosis Outcomes?
A new meta-analysis couldn't prove that oral or enteral nutritional supplements help patients with cirrhosis, but the Canadian researchers remain hopeful. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

EASL calls on UK to tackle alcohol consumption problem through implementation of minimum pricing
(European Association for the Study of the Liver) EASL urges UK government to press ahead with proposed implementation of the minimum unit pricing of alcohol. EASL's most publication The burden of liver disease in Europe: a review of available epidemiological data highlights the fact that alcohol consumption is one the leading causes of cirrhosis in Europe. Alcohol is the main cause of liver disease, including liver cirrhosis, and there is a clear correlation between an increase in alcohol-related cirrhosis and increases in alcohol consumption. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 13, 2013 Category: Global & Universal Source Type: news

Acute Variceal Bleed Treatments in Cirrhotic PatientsAcute Variceal Bleed Treatments in Cirrhotic Patients
How do variceal bleed treatments work for patients with various liver diseases, including cirrhosis? The American Journal of Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 28, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Mouse Research May Lead To Liver Stem Cell Therapy For Chronic Liver Disease In Humans
For decades scientists around the world have attempted to regenerate primary liver cells known as hepatocytes because of their numerous biomedical applications, including hepatitis research, drug metabolism and toxicity studies, as well as transplantation for cirrhosis and other chronic liver conditions. But no lab in the world has been successful in identifying and growing liver stem cells in culture -- using any available technique - until now... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 27, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Publication Of First Comprehensive Literature Review On The Burden Of Liver Disease In Europe: EASL
Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition. The European Association for the Study of the Liver (EASL) has unveiled its new publication The burden of liver disease in Europe: a review of available epidemiological data. Key findings in the report suggest that alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 25, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

OHSU scientists first to grow liver stem cells in culture, demonstrate therapeutic benefit
(Oregon Health & Science University) For decades scientists around the world have attempted to regenerate primary liver cells known as hepatocytes because of their numerous biomedical applications, including hepatitis research, drug metabolism and toxicity studies, as well as transplantation for cirrhosis and other chronic liver conditions. But no lab in the world has been successful in identifying and growing liver stem cells in culture -- using any available technique -- until now. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 25, 2013 Category: Global & Universal Source Type: news

How Surprisingly Potent Hepatitis C Drug Works Revealed By Computer Modeling
A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs - within 12 hours of treatment. Chronic infection with hepatitis C virus affects about 150 million people worldwide. It is the leading cause of cirrhosis, liver cancer and liver transplants and results in some 350,000 deaths worldwide every year... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 22, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

EASL publishes first comprehensive literature review on the burden of liver disease in Europe
(European Association for the Study of the Liver) Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition.Key findings in the report suggest that alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 21, 2013 Category: Global & Universal Source Type: news

Hepatitis C New Study On Drug Treatment In Vivo And In Vitro
Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 20, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

It Seems No One Ever Dies a Natural Death
When people die, it is not unusual to blame somebody—anybody.read more (Source: Psychology Today Relationships Center)
Source: Psychology Today Relationships Center - February 19, 2013 Category: Psychiatry & Psychology Authors: Fredric Neuman, M.D. Tags: Behavioral Economics Health Integrative Medicine Relationships acid indigestion bill of health brother cirrhosis dad death drugs dying elevator GERD heart attack hepatitis liver transplant magical thinking. nbsp nbsp nb Source Type: news

Early PBC prognosis advocated
Biochemical response to ursodeoxycholic acid at 6 months is a better predictor for primary biliary cirrhosis prognosis than the current standard of 1 year, study results suggest. (Source: MedWire News - Gastroenterology)
Source: MedWire News - Gastroenterology - February 19, 2013 Category: Gastroenterology Source Type: news

95 patients infected with hepatitis C linked to Chinese clinic
Hepatitis C causes liver disease which can range from a mild illness to a serious, lifelong condition that can lead to cirrhosis or liver cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 5, 2013 Category: Consumer Health News Source Type: news

Featured in Journal Watch: Preventing Death from Septic Shock in Cirrhosis
(Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 3, 2013 Category: Primary Care Tags: Medical News Source Type: news

The Effects Of Binge Drinking On The Liver
Alcoholic liver disease (ALD) is characterized by a fatty liver, hepatitis, fibrosis, and cirrhosis. Binge drinking is on the rise worldwide, and is particularly common in the U.S. A review of studies addressing the effects of binge drinking on the liver underscores the complex interactions among various immune, signaling pathways, epigenetic, and metabolic responses of the liver to binge drinking. Results will be published in the April 2013 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news

Harmful Cells May Have A Role To Play In Liver Repair, Study Suggests
Liver damage could be repaired by the same cells that harm the organ in the first place, a study suggests. The cells - called macrophages - cause tissue to become scarred, which can lead to cirrhosis of the liver. Scientists at the University of Edinburgh have now found that the macrophages also have a role in breaking down and getting rid of damaged tissue so that the normal liver structure and function is restored. Macrophages are found throughout the body and help fight infection by breaking down bacteria... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 18, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Pulmonary Complications of CirrhosisPulmonary Complications of Cirrhosis
The key pulmonary vascular complications of cirrhosis are comprehensively reviewed. Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 16, 2013 Category: Consumer Health News Tags: Gastroenterology Expert Column Source Type: news

The Importance Of Interleukin (IL)-28 For Hepatitis C Treatment
A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response to pegylated interferon-α plus ribavirin (PEG-IFN/RBV). Information about IL28B genotype could be used to provide personalized medicine and target treatment options effectively. Over 200 million people worldwide are chronically infected with hepatitis C virus (HCV) and about a quarter of these will go on to develop cirrhosis of the liver... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 8, 2013 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Anti-HBV Nucleos(t)ide Analogues in HBV/HCV CirrhosisAnti-HBV Nucleos(t)ide Analogues in HBV/HCV Cirrhosis
What is the most effective way to treat HBV/HCV chronic co-infections? Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

UPDATE: After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news

After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news

Increased risk of fractures seen in patients with cirrhosis
NEW YORK (Reuters Health) - Patients with cirrhosis face an increased risk of orthopedic fracture, researchers from Taiwan report. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news